Agfa-Gevaert N.V. (AFGVF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Agfa-Gevaert N.V. (AFGVF) with AI Score 42/100 (Weak). Agfa-Gevaert NV is a global developer, producer, and distributor of analog and digital imaging systems, as well as IT solutions. Market cap: 0, Sector: Industrials.
Last analyzed: Mar 16, 2026Agfa-Gevaert N.V. (AFGVF) Industrial Operations Profile
Agfa-Gevaert NV, founded in 1867, provides imaging solutions and IT services across diverse sectors, including printing, healthcare, and industrial applications. With a global reach and a focus on both analog and digital technologies, the company caters to specialized needs in hospitals, printing companies, and industrial manufacturers.
Investment Thesis
Agfa-Gevaert NV presents a complex investment case. The company's diverse portfolio across imaging and IT solutions offers exposure to multiple sectors, including healthcare and printing. However, its negative P/E ratio of -1.00 and a negative profit margin of -6.4% indicate profitability challenges. The company's beta of 0.58 suggests lower volatility compared to the market. Growth catalysts include expansion in the digital printing and healthcare IT segments. Investors should carefully consider the company's financial performance and competitive positioning before making investment decisions.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $0.09 billion reflects its current valuation in the market.
- Negative P/E ratio of -1.00 indicates the company is currently not profitable.
- Gross margin of 30.1% shows the percentage of revenue exceeding the cost of goods sold.
- Beta of 0.58 suggests the stock is less volatile than the overall market.
- The company operates in four segments: Offset Solutions, Radiology Solutions, Healthcare IT, and Digital Print & Chemicals.
Competitors & Peers
Strengths
- Diverse product portfolio across multiple segments.
- Global sales and distribution network.
- Expertise in both analog and digital technologies.
- Established brand reputation in the imaging industry.
Weaknesses
- Negative profitability and P/E ratio.
- Exposure to cyclical industries, such as printing.
- Competition from larger and more diversified companies.
- Dependence on specific markets and customers.
Catalysts
- Ongoing: Expansion in the healthcare IT market, driven by the increasing adoption of digital solutions in healthcare.
- Ongoing: Growth in the digital printing market, fueled by the demand for customized and short-run printing.
- Upcoming: Potential partnerships with hydrogen technology companies to develop membranes for hydrogen production.
- Ongoing: Focus on product innovation and expansion in specialty films and materials.
- Ongoing: Geographic expansion in emerging markets to increase global reach and revenue.
Risks
- Potential: Technological obsolescence in the imaging industry.
- Potential: Economic downturns affecting demand for printing and industrial products.
- Ongoing: Increased competition from larger and more diversified companies.
- Potential: Regulatory changes impacting the healthcare and printing industries.
- Ongoing: Negative profitability and P/E ratio indicating financial challenges.
Growth Opportunities
- Expansion in Healthcare IT Solutions: Agfa-Gevaert can capitalize on the growing demand for healthcare IT solutions, including picture archiving and communication systems (PACS) and hospital information systems (HIS). The global healthcare IT market is projected to reach $440.2 billion by 2026, offering significant growth potential. By focusing on integrated care solutions and expanding its customer base in hospitals and imaging centers, Agfa-Gevaert can increase its market share and revenue.
- Growth in Digital Printing and Industrial Inks: The digital printing market is expanding rapidly, driven by the increasing demand for customized and short-run printing. Agfa-Gevaert's Digital Print & Chemicals segment can benefit from this trend by offering inkjet printers, inks, and fluids for various industrial applications. The global digital printing market is expected to reach $40.8 billion by 2026. By developing innovative ink formulations and expanding its product portfolio, Agfa-Gevaert can strengthen its position in this market.
- Development of Hydrogen Production Membranes: Agfa-Gevaert's expertise in membrane technology can be leveraged to develop membranes for hydrogen production. The demand for hydrogen as a clean energy source is increasing, driving the need for efficient and cost-effective hydrogen production methods. The global hydrogen generation market is projected to reach $201 billion by 2030. By investing in research and development and partnering with hydrogen technology companies, Agfa-Gevaert can tap into this emerging market.
- Focus on Specialty Films and Materials: Agfa-Gevaert's Digital Print & Chemicals segment offers specialty films for various applications, including micrography, non-destructive testing, and security documents. These films cater to niche markets with specific requirements. By focusing on product innovation and expanding its customer base in these markets, Agfa-Gevaert can generate stable revenue streams and improve its profitability.
- Geographic Expansion in Emerging Markets: Agfa-Gevaert can expand its presence in emerging markets, where the demand for imaging solutions and IT services is growing rapidly. By establishing partnerships with local distributors and tailoring its products to meet the specific needs of these markets, Agfa-Gevaert can increase its global reach and revenue. Emerging markets offer significant growth opportunities due to their increasing healthcare spending and industrial development.
Opportunities
- Expansion in healthcare IT solutions.
- Growth in digital printing and industrial inks.
- Development of hydrogen production membranes.
- Geographic expansion in emerging markets.
Threats
- Technological obsolescence.
- Economic downturns.
- Increased competition.
- Regulatory changes.
Competitive Advantages
- Established brand reputation in the imaging industry.
- Extensive product portfolio across multiple segments.
- Global sales and distribution network.
- Expertise in both analog and digital technologies.
About AFGVF
Agfa-Gevaert NV, established in 1867 and headquartered in Mortsel, Belgium, has evolved from a manufacturer of photographic materials to a provider of comprehensive imaging solutions and IT services. The company operates through four primary segments: Offset Solutions, Radiology Solutions, Healthcare IT, and Digital Print & Chemicals. The Offset Solutions segment offers integrated prepress and printing solutions, including computer-to-plate systems, pressroom supplies, and workflow software. The Radiology Solutions segment provides analog and digital imaging technologies for diagnostic purposes, including X-ray film, digital radiography equipment, and image processing software. The Healthcare IT segment delivers picture archiving and communication systems, hospital information systems, and integrated care solutions. The Digital Print & Chemicals segment focuses on inkjet printers, inks, and fluids for various industrial applications, as well as specialty films and materials. Agfa-Gevaert sells its products through its own sales organization and a network of agents and representatives worldwide.
What They Do
- Develops and distributes analog and digital imaging systems.
- Provides IT solutions for healthcare and industrial applications.
- Offers integrated prepress and printing solutions for commercial, newspaper, and packaging printers.
- Supplies X-ray film, hardcopy film, and digital radiography equipment for diagnostic imaging.
- Delivers picture archiving and communication systems (PACS) for hospitals and imaging centers.
- Produces inkjet printers, inks, and fluids for industrial inkjet applications.
- Manufactures specialty films for micrography, non-destructive testing, and security documents.
Business Model
- Develops and sells imaging hardware and software solutions.
- Provides IT services and support to healthcare providers.
- Generates revenue through sales of consumables, such as film and ink.
- Offers maintenance and service contracts for its equipment.
Industry Context
Agfa-Gevaert NV operates in the industrial machinery sector, which is influenced by technological advancements and economic cycles. The company faces competition from established players and new entrants in each of its segments. The healthcare IT market is experiencing growth due to the increasing adoption of digital solutions in healthcare. The printing industry is evolving with the shift towards digital printing technologies. Agfa-Gevaert's ability to innovate and adapt to these trends will be crucial for its success.
Key Customers
- Commercial, newspaper, and packaging printers.
- Hospitals and imaging centers.
- Sign and display printing companies.
- Industrial manufacturers using inkjet printing.
- Organizations requiring specialty films for security documents and print media.
Financials
Chart & Info
Agfa-Gevaert N.V. (AFGVF) stock price: Price data unavailable
Latest News
No recent news available for AFGVF.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AFGVF.
Price Targets
Wall Street price target analysis for AFGVF.
MoonshotScore
What does this score mean?
The MoonshotScore rates AFGVF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Pascal Juery
CEO
Pascal Juery has served as the CEO of Agfa-Gevaert since 2015. Prior to joining Agfa-Gevaert, he held various leadership positions at Rhodia and Solvay, where he gained extensive experience in the chemical and materials industries. He holds a degree in Chemical Engineering from École Polytechnique and an MBA from INSEAD.
Track Record: Under Pascal Juery's leadership, Agfa-Gevaert has focused on transforming its business model and investing in growth areas, such as healthcare IT and digital printing. He has overseen the company's efforts to streamline its operations, reduce costs, and improve its financial performance. Key milestones include the acquisition of several healthcare IT companies and the launch of new digital printing products.
AFGVF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Agfa-Gevaert N.V. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and performance. Investing in OTC Other stocks carries higher risks compared to stocks listed on major exchanges due to the lack of regulatory oversight and transparency.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases information asymmetry.
- Lower liquidity can lead to price volatility.
- Higher potential for fraud and manipulation.
- OTC Other stocks may be subject to less regulatory oversight.
- Delisting risk if the company fails to meet minimum requirements.
- Verify the company's financial statements and audit reports.
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Review the company's legal and regulatory filings.
- Check for any history of fraud or misconduct.
- Understand the risks associated with investing in OTC stocks.
- Consult with a qualified financial advisor.
- Company has been in operation since 1867.
- Presence in multiple segments: Offset Solutions, Radiology Solutions, Healthcare IT, and Digital Print & Chemicals.
- Global sales and distribution network.
- CEO with prior experience at Rhodia and Solvay.
- The company has a substantial number of employees (4765).
AFGVF Industrials Stock FAQ
What does Agfa-Gevaert N.V. do?
Agfa-Gevaert NV develops, produces, and distributes a range of imaging systems and IT solutions. Its operations are divided into four segments: Offset Solutions, providing printing solutions; Radiology Solutions, offering diagnostic imaging technology; Healthcare IT, delivering healthcare information systems; and Digital Print & Chemicals, producing inkjet printers and specialty films. The company serves diverse sectors, including printing, healthcare, and industrial manufacturing, with a global sales and distribution network.
What do analysts say about AFGVF stock?
As of 2026-03-16, formal analyst ratings for AFGVF may be limited due to its OTC listing. Key valuation metrics include a market cap of $0.09 billion and a negative P/E ratio of -1.00. Growth considerations revolve around the company's ability to capitalize on opportunities in healthcare IT and digital printing. Investors should conduct their own due diligence and consider the risks associated with OTC stocks before investing.
What are the main risks for AFGVF?
Agfa-Gevaert faces several risks, including technological obsolescence in the imaging industry, economic downturns affecting demand for its products, and increased competition from larger companies. Its negative profitability and P/E ratio indicate financial challenges. As an OTC-listed stock, AFGVF is subject to risks related to limited financial disclosure, lower liquidity, and less regulatory oversight. These factors contribute to a higher risk profile for investors.
What are the key factors to evaluate for AFGVF?
Agfa-Gevaert N.V. (AFGVF) currently holds an AI score of 42/100, indicating low score. Key strength: Diverse product portfolio across multiple segments.. Primary risk to monitor: Potential: Technological obsolescence in the imaging industry.. This is not financial advice.
How frequently does AFGVF data refresh on this page?
AFGVF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven AFGVF's recent stock price performance?
Recent price movement in Agfa-Gevaert N.V. (AFGVF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diverse product portfolio across multiple segments.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider AFGVF overvalued or undervalued right now?
Determining whether Agfa-Gevaert N.V. (AFGVF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying AFGVF?
Before investing in Agfa-Gevaert N.V. (AFGVF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- OTC data may have limited availability and reliability.
- AI analysis pending for AFGVF.